Sigma Planning Corp Zomedica Corp. Transaction History

Sigma Planning Corp

$3.22 Billion
Q3 2024

A detailed history of Sigma Planning Corp transactions in Zomedica Corp. stock. As of the latest transaction made, Sigma Planning Corp holds 180,400 shares of ZOM stock, worth $25,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares

180,400

Previous 180,400 -0.0%

Holding current value

$25,256

Previous $27,000 7.41%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$0.12 - $0.18 $2,388 - $3,582	19,900 Added 12.4%	180,400 $27,000
Q1 2024 May 01, 2024	BUY	$0.12 - $0.19 $19,260 - $30,495	160,500 New	160,500 $24,000
Q3 2023 Nov 06, 2023	BUY	$0.16 - $0.23 $6,399 - $9,199	39,999 Added 53.69%	114,500 $19,000
Q2 2023 Aug 01, 2023	SELL	$0.19 - $0.22 $1,377 - $1,595	-7,250 Reduced 8.87%	74,501 $14,000
Q1 2023 May 05, 2023	BUY	$0.16 - $0.29 $0 - $0	1 Added 0.0%	81,751 $17,000
Q3 2022 Nov 10, 2022	SELL	$0.2 - $0.38 $200 - $380	-1,000 Reduced 1.21%	81,750 $17,000
Q2 2022 Aug 11, 2022	BUY	$0.2 - $0.34 $500 - $850	2,500 Added 3.12%	82,750 $18,000
Q1 2022 Apr 20, 2022	SELL	$0.28 - $0.4 $3,976 - $5,680	-14,200 Reduced 15.03%	80,250 $27,000
Q4 2021 Feb 02, 2022	BUY	$0.31 - $0.58 $3,100 - $5,800	10,000 Added 11.84%	94,450 $29,000
Q3 2021 Oct 28, 2021	SELL	$0.46 - $0.81 $6,440 - $11,340	-14,000 Reduced 14.22%	84,450 $44,000
Q2 2021 Aug 13, 2021	SELL	$0.72 - $1.46 $7,200 - $14,600	-10,000 Reduced 9.22%	98,450 $82,000
Q1 2021 May 06, 2021	BUY	$0.35 - $2.7 $15,557 - $120,015	44,450 Added 69.45%	108,450 $171,000
Q4 2020 Feb 09, 2021	BUY	$0.07 - $0.25 $4,480 - $16,000	64,000 New	64,000 $15,000

Others Institutions Holding ZOM

# of Institutions

Shares Held

80.9M

Call Options Held

Put Options Held

View Full List

About Zomedica Corp.

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $137M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

More about ZOM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Zomedica Corp. Transaction History